phototechno / iStockphoto.com
The US Supreme Court will today hear a patent dispute between Helsinn Healthcare and Teva Pharmaceuticals, with lawyers telling WIPR that the probable reversal in the case will have a wide-ranging impact.
If you have already subscribed please login.
If you have any technical issues please email tech support.
US Supreme Court, patentability, America Invents Act, Teva, Helsinn, on-sale bar, patent invalidation, Aloxi, palonosetron hydrochloride, statutory meaning
